Valuation: Quest Diagnostics Incorporated

Capitalization 21.2B 18.11B 16.7B 15.76B 29.28B 1,985B 30.02B 196B 76.89B 948B 79.55B 77.86B 3,386B P/E ratio 2026 *
20.3x
P/E ratio 2027 * 18.4x
Enterprise value 26.3B 22.47B 20.72B 19.55B 36.33B 2,463B 37.25B 243B 95.4B 1,176B 98.7B 96.61B 4,201B EV / Sales 2026 *
2.24x
EV / Sales 2027 * 2.12x
Free-Float
67.83%
Yield 2026 *
1.69%
Yield 2027 * 1.67%
1 day+0.73%
1 week-2.58%
Current month-1.57%
1 month-3.97%
3 months+9.65%
6 months+4.80%
Current year+11.17%
1 week 189.72
Extreme 189.72
201
1 month 189.72
Extreme 189.72
202.91
Current year 171.18
Extreme 171.175
213.5
1 year 160.02
Extreme 160.02
213.5
3 years 119.59
Extreme 119.59
213.5
5 years 119.59
Extreme 119.59
213.5
10 years 72.95
Extreme 72.95
213.5
Manager TitleAgeSince
Chief Executive Officer 63 02/02/2022
Director of Finance/CFO 56 10/07/2022
Compliance Officer - 31/07/2022
Director TitleAgeSince
Director/Board Member 76 30/11/2004
Director/Board Member 69 06/12/2011
Chairman 63 31/03/2023
Change 5d. change 1-year change 3-years change Capi.($)
+0.73%-2.58%+17.64%+35.40% 21.2B
+0.39%+5.42%+49.21%+82.62% 111B
-1.56%+6.26%+12.34%+4.23% 102B
-0.47%+2.09%+21.66%+76.06% 29.55B
+0.40%-0.95%-13.33%-6.06% 23.32B
+1.25%-3.49%+19.29%+14.71% 21.45B
+0.65%+4.88%+40.54%+76.57% 18.21B
-1.15%+2.56%+55.90%+207.21% 16.98B
-0.79%+3.49%-3.71%-0.67% 12.8B
+1.34%+3.68%+4.44%+36.63% 11.03B
Average +0.11%+2.07%+20.40%+52.67% 36.7B
Weighted average by Cap. -0.25%+3.97%+25.92%+49.22%

Financials

2026 *2027 *
Net sales 11.76B 10.05B 9.26B 8.74B 16.24B 1,101B 16.66B 108B 42.65B 526B 44.13B 43.19B 1,878B 12.21B 10.43B 9.62B 9.08B 16.87B 1,144B 17.3B 113B 44.3B 546B 45.84B 44.87B 1,951B
Net income 1.07B 916M 845M 797M 1.48B 100B 1.52B 9.89B 3.89B 47.95B 4.02B 3.94B 171B 1.17B 1B 924M 872M 1.62B 110B 1.66B 10.82B 4.26B 52.47B 4.4B 4.31B 187B
Net Debt 5.1B 4.36B 4.02B 3.79B 7.05B 478B 7.23B 47.08B 18.51B 228B 19.15B 18.75B 815B 4.69B 4B 3.69B 3.48B 6.47B 439B 6.64B 43.24B 17B 210B 17.59B 17.21B 749B
Logo Quest Diagnostics Incorporated
Quest Diagnostics Incorporated is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.4%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica-pathology diagnostic services; - other (2.6%).
Employees
51,500
Date Price Change Volume
13/04/26 192.91 $ +0.73% 898,996
10/04/26 191.51 $ -3.19% 1,044,169
09/04/26 197.82 $ -0.50% 718,355
08/04/26 198.81 $ +1.02% 799,277
07/04/26 196.81 $ -1.08% 908,927
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
191.51USD
Average target price
217.88USD
Spread / Average Target
+13.77%

Quarterly revenue - Rate of surprise